Difference between revisions of "Publication:20170310181047"
From Bioinformatics Core Wiki
Jponomarenko (Talk | contribs) |
Jponomarenko (Talk | contribs) |
||
| Line 3: | Line 3: | ||
}} | }} | ||
{{Annotation | {{Annotation | ||
| − | |Annotation=The BioCore collaborated with the geneticists from the University of Barcelona and the Opitz C Association on the analysis of the whole genomes of the Opitz C syndrome patient and her parents. In the result, a ''de novo'' nonsense mutation in MAGEL2 was discovered. | + | |Annotation=The BioCore collaborated with the geneticists from the University of Barcelona and the Opitz C Association on the analysis of the whole genomes of the Opitz C syndrome patient and her parents. In the result, a ''de novo'' nonsense mutation in MAGEL2 was discovered. Topics: WGS, rare disease. Impact Factor 4,1. |
}} | }} | ||
Latest revision as of 15:58, 9 June 2020
| Publication | |
|---|---|
| URL | http://www.nature.com/articles/srep44138 |
| Title | A De Novo Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as Opitz-C: Similarities Between Schaaf-Yang and Opitz-C Syndromes
|
| Authors | Roser Urreizti, Anna Maria Cueto-Gonzalez, Héctor Franco-Valls, Sílvia Mort-Farre, Neus Roca-Ayats, Julia Ponomarenko, Luca Cozzuto, Carlos Company, Mattia Bosio, Stephan Ossowski, Magda Montfort, Jochen Hecht, Eduardo F. Tizzano, Bru Cormand, Lluïsa Vilageliu, John M. Opitz, Giovanni Neri, Daniel Grinberg, Susana Balcells |
| Date | 2017-03-10
|
| Publisher | Scientific Reports |
| DOI | 10.1038/srep44138 |
| Tag | Molecular medicine, Neurodevelopmental disorders |
Abstract:
Opitz trigonocephaly C syndrome (OTCS) is a rare genetic disorder characterized by craniofacial anomalies, variable intellectual and psychomotor disability, and variable cardiac defects with a high mortality rate. Different patterns of inheritance and genetic heterogeneity are known in this syndrome. Whole exome and genome sequencing of a 19-year-old girl (P7), initially diagnosed with OTCS, revealed a de novo nonsense mutation, p.Q638*, in the MAGEL2 gene. MAGEL2 is an imprinted, maternally silenced, gene located at 15q11-13, within the Prader-Willi region. Patient P7 carried the mutation in the paternal chromosome. Recently, mutations in MAGEL2 have been described in Schaaf-Yang syndrome (SHFYNG) and in severe arthrogryposis. Patient P7 bears resemblances with SHFYNG cases but has other findings not described in this syndrome and common in OTCS. We sequenced MAGEL2 in nine additional OTCS patients and no mutations were found. This study provides the first clear molecular genetic basis for an OTCS case, indicates that there is overlap between OTCS and SHFYNG syndromes, and confirms that OTCS is genetically heterogeneous. Genes encoding MAGEL2 partners, either in the retrograde transport or in the ubiquitination-deubiquitination complexes, are promising candidates as OTCS disease-causing genes.
Opitz trigonocephaly C syndrome (OTCS) is a rare genetic disorder characterized by craniofacial anomalies, variable intellectual and psychomotor disability, and variable cardiac defects with a high mortality rate. Different patterns of inheritance and genetic heterogeneity are known in this syndrome. Whole exome and genome sequencing of a 19-year-old girl (P7), initially diagnosed with OTCS, revealed a de novo nonsense mutation, p.Q638*, in the MAGEL2 gene. MAGEL2 is an imprinted, maternally silenced, gene located at 15q11-13, within the Prader-Willi region. Patient P7 carried the mutation in the paternal chromosome. Recently, mutations in MAGEL2 have been described in Schaaf-Yang syndrome (SHFYNG) and in severe arthrogryposis. Patient P7 bears resemblances with SHFYNG cases but has other findings not described in this syndrome and common in OTCS. We sequenced MAGEL2 in nine additional OTCS patients and no mutations were found. This study provides the first clear molecular genetic basis for an OTCS case, indicates that there is overlap between OTCS and SHFYNG syndromes, and confirms that OTCS is genetically heterogeneous. Genes encoding MAGEL2 partners, either in the retrograde transport or in the ubiquitination-deubiquitination complexes, are promising candidates as OTCS disease-causing genes.
| Annotation | The BioCore collaborated with the geneticists from the University of Barcelona and the Opitz C Association on the analysis of the whole genomes of the Opitz C syndrome patient and her parents. In the result, a de novo nonsense mutation in MAGEL2 was discovered. Topics: WGS, rare disease. Impact Factor 4,1. |
|---|
